Vancomycin-resistant enterococcal bacteremia in neutropenic patients with cancer;Bacteriemia por enterococos resistentes a vancomicina en los pacientes neutropenicos con cancer

Medicina Clinica

Volumn 111, Issue 20, 1998, Pages 761-764

  Marron, Anna ^a   Carratalà, Jordi ^a   Ayats, Josefina ^a   De Sevilla, Alberto Fernández ^a   Domínguez, María Ángeles ^a   Liñares, Josefina ^a   Gudiol, Francesc ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTAZIDIME; GENTAMICIN; IMIPENEM; METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; CANCER PATIENT; CATHETER INFECTION; CLINICAL ARTICLE; COMORBIDITY; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; LEUKEMIA; LYMPHOMA; MALE; NEUTROPENIA; SINUSITIS; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; VANCOMYCIN;

EID: 0032512357     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis: an increasing casue of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 507-508.
2. EORTC International Antimicrobial Therapy Cooperative Group. Grampositive bacteraemia in granulocytopenic cancer patients. Eur J Cancer 1990; 26: 569-574.
3. González-Barca E, Fernández-Sevilla A, Carratalà J, Grañena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neytropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996; 15: 291-296.
4. Awada A, Van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and exuterococcal bacteremia in patients with cancer. Clin Infect Dis 1992; 15, 33-48
5. Carratalà J, Alcaide F, Fernández-Sevilla A, Corbella X, Liñares J, Gudiol F. Bacteremia due to viridans streptococci: a case highly resistant to penicilin: increase among neutropenic patients with cancer. Clin Infect Dis 1995; 20: 1.169-1.173.
6. Elting LS, Bodey GP, Keele BH. Septicemia and shock syndrome due to viridans strepto: a case-control study of predisposing factors. Clin Infect Dis 1992; 14: 1.201-1.207.
7. Bochud PY, Egglman PH, Calandra TH, Van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994; 18: 25-31.
8. Winston DJ, Dudnick DV, Chapin M, Ho WG, Gale RP, Martín WJ. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppresivve therapy. Arch Intern Med 1983; 143: 32-36.
9. Cruciani M, Rampazzo R, Malena M, Lazzarini L, Todeschini G, Messori A et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta analisys. Clin Infect Dis 1996; 23: 795-805.
10. Karp JE, Hich JD, Angelopulos C, Charache P, Green L, Burke PJ, et al. Empiric use of vancomycin during prolonged treatment-induced neutropenia. Am J Med 1986; 81: 237-242.
11. Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
12. Frieden TR, Munsiff SS, Low DE, Willey BM, Willians G, Faur Y et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-79.
13. Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-259.
14. Moreno F, Grota P, Crisp C, Magnon K, Melcher GP, Jorgensen JH et al. Clinical and molecular epidemiology of vancomycin-resistant. Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995; 21: 1.234-1.237.
15. Gaynes R, Edwards J. National Nosocomial Infection Surveillance System. Mosocomial vancomysin resistant enterococci in the United States. 1989-1995; the fortst 1.000 isolates [resumen 13] Infect Control Hosp Epidemiol 1996; 17 (Supl): 18.
16. Balas D, Perea B, Wilhelmi I, Romanyk J, Alós JI, Gómez-Garcés JL. Prevalencia de resistencia antimicrobiana en enterococos aislados en sangre en Madrid (1994-1995). Enferm Infec Microbiol Clin 1997; 15: 22-23.
17. a ed.), NCCLS, document M2-A6. Wayne, Pa, EE.UU.: NCCLS, 1997.
18. Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24: 545-556.
19. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicilin and gentamicin, Clin Infect Dis 1993; 16: 750-755.
20. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A et al. Outbreak of vancomycin, ampicillin and ammoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1.363-1.367.
21. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1.148-1.153.
22. Alonso T, Peréz JL, Liñares J. Enterococos con resistencia adquirida a los antibioticos. Enferm Infecc Microbiol Clin 1992; 10: 489-496.
23. Cercenado E. Resistencia de los enterococos a antibióticos glucopeptidicos. Rev Clin Esp 1995; 195 (Supl 4): 22-27.
24. Navarro F. Mecanismos de resistencia a los glicopéptidos. Enferm Infecc Microbiol Clin 1996; 14: 317-323.
25. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemoiher 1989; 33: 10-15.
26. Power EGM, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL. VanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995; 36: 595-606.
27. Noble WC, Virani Z, Cree RGA, Co-transfer of vancomycin and other resistant genes from Enterococccus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198.
28. Montecalvo MA, Shay DK, Patel P, Tacsa L, Maloney SA, Jarvis WR et al. Bloodstream infections with vancomycm-resistant enterococci. Arch Intern Med 1996; 156: 1.458-1.462.
29. Guiot HFL, Peetermans WE, Sebens FW, Isolation of vancomycin-resistant enterococci in haematologic patients. Eur J Clin Microbiol Infect Dis 1991; 10: 32-34.
30. Peetermans WE, Sebens FW, Guiot HFL. Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient. Scand J Infect Dis 1991; 23: 105-109.
31. Plessis P, Laury T, Donnio PY, Autuly F, Grulois I, Le Prise PY et al. Epidemiologic analysis of glytropenic-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur J Clin Microbiol Infect Dis 1995; 14: 959-963.
32. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172: 993-1.000
33. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993; 269: 598-602.
34. Tornieporth NG, Roberts RB, John J, Hafner A, Riley' LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767-772.
35. Livornese LL Jr, Dias S, Samel C, Romanowski B, Taylos S, May P et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112-116.
36. Bonten MJM, Hayden MK, Nathan C, Voorhis JV, Matushek M, Slaughter S et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterocci. Lancet 1996; 348: 1.615-1.619.
37. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996, 23: 1.234-1.239.